Dr Molecular Biology, Biomedicine and Health

Pedro E. Guerrero .

Position: Doctor colaborador Junior

Phone:

(+34) 876 555 461

Email:

pedro.guerrero@unizar.es

Degree in biotechnology. Master’s studies completed in the Pompeu Fabra University in the field of biomedical research. International PhD in Molecular Biology, Biomedicine and Health about novel Pancreatic cancer biomarkers and new therapeutic strategies.

Profile

Primage
2018-2022

Predictive insilico multiscale analytics to support cancer personalized diagnosis and prognosis, empowered by imaging biomarkers.

European Union
H2020-SC1(Health),(GA 826494).

Cancer research

Microfluidics

Cell migration

Mechanosensing

Microfibril associated protein 4 (MFAP4) is a carrier of the tumor associated carbohydrate sialyl-Lewis x (sLex) in pancreatic adenocarcinomaPrimary human osteoblasts cultured in a 3D microenvironment create a unique representative model of their differentiation into osteocytes.

Journal of Proteomics

Journal of Proteomics 2021-01

Knockdown of α2,3-Sialyltransferases Impairs Pancreatic Cancer Cell Migration, Invasion and E-selectin-Dependent Adhesion International Journal of Molecular Sciences

2020-08-28

Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk.Proceedings of the National Academy of Sciences of the United States of America

2018-04

Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinomaWorld Journal of Gastroenterology Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific ChangesTheranostics

2016

Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific ChangesTheranostics2016 | journal-article DOI

The pancreatic niche inhibits the effectiveness of sunitinib treatment of pancreatic cancer Oncotarget

2016

Phd stays

2019 – Stay in the chemical and biomolecular engineering department. The Johns Hopkins University. Baltimore, MD. USA